Trials / Unknown
UnknownNCT04974905
Retrograde Recanalization of Infrainguinal Arterial Occlusive Disease.
Retrograde Approach for Management of Infrainguinal Arterial Occlusive Disease After Failed Antegrade Approach in Critical Limb Ischemia Patients; Feasibility, Safety, and Procedure Related Outcomes.
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 40 (estimated)
- Sponsor
- Sohag University · Academic / Other
- Sex
- All
- Age
- 35 Years – 95 Years
- Healthy volunteers
- Not accepted
Summary
The spectrum of lower extremity peripheral arterial disease (PAD) ranges from exhibiting no symptoms to limb threatening gangrene. The number of patients living with it is rising steadily owing to increased life expectancy, obesity, diabetes, and tobacco consumption. Critical limb ischemia (CLI) is the terminal and the most serious stage of PAD in which blood flow to the lower extremity does not meet metabolic demands of the tissues at rest. The diagnosis is mainly clinical and patients are presented with rest pain, minimal tissue loss or frank gangrene. Revascularization strategies include endovascular procedures and surgical bypass.Endovascular therapy has evolved as an attractive, minimally invasive method of revascularization especially in the more frequently encountered patients with medical and anatomical contraindications to surgical revascularization. Antegrade approach is the standard approach in infrainguinal arterial occlusive disease,however, failure occurs in about 20% of infrainguinal attempts.Retrograde approach is used as a backup technique in failed cases.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | retrograde access for re-canalization of infra-inguinal arterial occlusive disease | after failed antegrade approach for re-canalization of infra-inguinal arterial occlusive disease( failed reentry into the distal true lumen), the retrograde approach will be attempted |
Timeline
- Start date
- 2021-08-01
- Primary completion
- 2022-08-01
- Completion
- 2022-08-01
- First posted
- 2021-07-23
- Last updated
- 2021-07-23
Source: ClinicalTrials.gov record NCT04974905. Inclusion in this directory is not an endorsement.